STAT3 DECOY in Head and Neck Cancer
NCT00696176
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
32
Enrollment
OTHER
Sponsor class
Conditions
Head and Neck Cancer
Interventions
DRUG:
STAT 3 DECOY
Sponsor
University of Pittsburgh